DISCOUNT-ZERTIFIKAT - THYP NUCENPV Stock

Certificat

DE000SU9H589

Real-time Boerse Frankfurt Warrants 07:18:08 2024-07-08 EDT
10.19 EUR -1.16% Intraday chart for DISCOUNT-ZERTIFIKAT - THYP NUCENPV
Current month+14.94%
1 month-7.28%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-08 10.19 -1.16%
24-07-05 10.31 +2.59%
24-07-04 10.05 +4.04%
24-07-03 9.66 +5.57%
24-07-02 9.15 -0.11%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 07:18 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying THYSSENKRUPP NUCERA AG & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU9H58
ISINDE000SU9H589
Date issued 2024-02-19
Cap 18
Last trading day 2024-09-19
Maturity 2024-09-20 (74 Days)
Parity 1 : 1
Emission price 15.39
Emission volume N/A
Payment day 2024-09-27
Bonus-
Settlement les deux
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point-
Break even 0.000000 €
Highest since issue 15.32
Lowest since issue 8.96
Distance Cap -7.915
Distance Cap %-78.48%
Max. earning-
Max. earning % 0.000000 %

Company Profile

thyssenkrupp nucera AG & Co. KGaA, formerly Thyssenkrupp Uhde Chlorine Engineers Gmbh, is a Germany-based company, which operates as an electrolysis technology provider. The Company's business consists of the design, engineering and procurement of electrolysis technologies and the plants into which they are incorporated, as well as the provision of aftermarket services for existing plants. The Company provides green hydrogen solutions, Chlor-alkali solutions, and hydrochloric acid solutions.
Sector
-
More about the company

Ratings for thyssenkrupp nucera AG & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: thyssenkrupp nucera AG & Co. KGaA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
10.48 EUR
Average target price
18.79 EUR
Spread / Average Target
+79.31%
Consensus